Aro Biotherapeutics’ Post

WEBINAR REGISTRATION: Nanopore Sequencing: Driving Research Insights from Neonatal Intensive Care to Cancer Date: Thursday, November 09, 2023 Time: 1:00 PM Eastern Standard Time Duration: 1 hour Long-read nanopore sequencing has the potential to improve both the speed and yield of genetic characterization and information. In this webinar, Steven Jones from the Michael Smith Genome Sciences Centre will discuss the benefits of long-read nanopore sequencing for a range of research applications. His presentation will cover how: Long reads can more accurately discover and define large-scale structural variation, and the alignment of long reads can provide a more accurate assessment of regions that are highly repetitive and duplicated; Using epigenomic signals associated with sequencing data can help confirm the pathogenicity for variants initially determined to be of unknown significance, thereby improving time to results, and potentially diagnosis; Detection of phased methylation can determine imprinted regions, and coupling this information with long-range haplotyping allows assignment of parental origin of all human autosomes, which could significantly increase the speed and reduce the cost of hereditary cancer testing. https://lnkd.in/g5ihb9ui

A CRISPR Workflow to Increase Efficacy of CAR-T Engineering and Screening Potent synthetic single guide RNAs (sgRNAs) are critical for functional gene characterization in primary cell models. This is because primary cells are more sensitive and resistant to CRISPR genome engineering than immortalized cancer cell lines. Tune in to our upcoming webinar (March 26, 11 a.m. ET) to gain insight in engineering CD8+ chimeric antigen receptor (CAR) T cells. Register here. https://lnkd.in/gFSkF229 #revvity #biolegend #crispr

Did you know that I offer conference coverage? I recently covered an oral abstract session at WCLC. Check it out below. How I can assist you: •Immerse myself in the action: I attend key symposia, presentations, product theatres, and poster sessions on your behalf. •Connect with key opinion leaders: I interview thought leaders, MDs, and industry experts to provide you with valuable insights. •Snapshot of the competition: I capture booth materials and images, revealing competitor tactics. •Daily insights: I create concise newsletters, delivering the most crucial updates directly to your team. •Detailed reports: I curate comprehensive reports summarizing the sessions I cover exclusively for you. •Executive summaries: I create comprehensive executive summaries, highlighting the pivotal takeaways from the conference. Ready to make the most of your conference experience and gain a competitive edge? Reach out now to discuss your needs!

Discover why top healthcare systems like Cedars-Sinai, City of Hope, MSK, UCSF, Stanford Medicine, and others are showcasing their innovations at PMWC 2024, happening January 24-26 in Silicon Valley. 90 Exhibitors include in Alphabetic order: Castle Biosciences, Inc. Biosciences: Specializes in innovative diagnostic tests that inform patient care and aim to revolutionize how diseases are managed. Ceres Nanosciences, Inc.: Nanotechnology-based liquid biopsy platform for early cancer detection. Certis Oncology Solutions, Inc.: offers precision oncology technology, utilizing AI for predictive cancer therapy response, supported by advanced biological models. CITO Medical: Develops medical devices and diagnostics. Claret Bioscience: Enhances NGS library preparation for high-quality sequencing from challenging samples, improving disease profiling accuracy. Complete Genomics: High-throughput whole-genome sequencing for precision medicine research. COZEVA - Applied Research Works, Inc: Comprehensive health management platform focusing on quality performance, risk adjustment, and care cost optimization. Cytiva: Provides comprehensive life science solutions, combining technologies, services, and expertise to support the development of transformative medicines. Dandelion Health: Product & data infrastructure platform catalyzing the development of healthcare AI. DNA Genotek: Products for collecting high-quality biological samples for DNA and RNA testing, ensuring superior sample performance for reliable nucleic acid analysis. DrugBank: The world's first intelligent and comprehensive drug knowledge platform. Epredia: Delivers comprehensive pathology lab solutions, including state-of-the-art instruments, consumables, and services. Fabric Genomics: Provides an AI-driven NGS platform for genetic disease, cancer testing, and risk assessment. Foresight Diagnostics Inc.: Advancing liquid biopsy with a sensitive MRD test to inform personalized cancer treatments. Foundation Medicine: Develops advanced genomic profiling tests to tailor cancer treatment with targeted therapies and clinical trials. GenepoweRx: Pharmacogenomic testing to optimize medication response and reduce adverse drug reactions. Genetika+: Clinical genetics testing for various inherited conditions and personalized health risks. Gentueri: Streamlines lab operations with innovative kits for efficient biological sample collection, preservation, and transport. Gero ai: AI-driven drug discovery focused on therapies targeting aging and age-related diseases. GRAIL: Cancer detection and monitoring company using next-generation sequencing technology. Guardant Health: Focused on helping conquer cancer through the use of its proprietary blood tests, vast data sets, and advanced analytics. Guardian Research Network: Consortium with the mission to speed the identification of trial participants. Full list: https://lnkd.in/gQ9yx5C4 PMWC - Precision Medicine World Conference #PMWC24

🌍 On Lung Cancer Awareness Month, let's reflect on the importance of raising awareness and supporting research in this area. Lung cancer remains one of the leading causes of death worldwide. 🔬 HAWK Biosystems is committed to research and exploring more precise ways to approach immunotherapy, with the potential to significantly improve responses and survival. 🌟 These advancements aim not only to enhance the treatment landscape but also to optimize investments for more effective outcomes. 🔍 Current research could change the game in the fight against lung cancer, offering hope to those battling this disease. 🏥 Very soon our technology will contribute to this advancement in lung cancer treatment. Read more: https://lnkd.in/eJpGCmz4 Together, we move towards a future with better responses to lung cancer. Join the fight!

Come join this webinar on 28th Feb 2024!

check our recently published @ACSOmega

ONE partner to address your Precision Medicine Oncology needs. Check out our posters and abstracts and schedule a meeting here or message me via DM if you'd like to meet. #Biomarkers #PrecisionMedicine #CDx #ctDNA #LiquidBiopsy #GenomicProfiling #ImmuneProfiling #ClinicalDevelopment #Commercialization

At the 2nd Congress of the Romanian Society of Apitherapy, Phytotherapy and Aromatherapy , which took place in Constanta, between May 24-27, 2024, Dr Mila Emerald Ph.D., Dr. Sci., had an exceptional presentation entitled: "Therapeutic applications and nanodelivery of apitherapy, phytotherapy and aromatherapy bio-active compounds targeting brain cancer and neurodegeneration"